US Global Jets ETF vs Revolution Medicines Inc. Common Stock — how do they compare? US Global Jets ETF trades at $27.38 (market cap $878.48M), while Revolution Medicines Inc. Common Stock trades at $191.11 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 45.9× US Global Jets ETF's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, US Global Jets ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold US Global Jets ETF for 26 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| JETS | RVMD | |
|---|---|---|
Market Cap | $878.48M | $40.32B |
Volume | 4,465,925 | 4,855,734 |
Sector | Sector/Thematic | Health |
52-Week High | $33.53 | $221.15 |
52-Week Low | $23.64 | $47.50 |
Typical Hold Time | 26 Days | 0 Days |
Enterprise Value | — | $37.02B |
Signals from Pluang's Aura AI — not financial advice
JETS ETF trades at $27.29, down 1.37% amid bearish technical signals with 17 sell indicators versus 4 buy signals. The airline-focused ETF faces headwinds from rising fuel costs and geopolitical tensions, while technical analysis shows strong resistance at $28 and support at $27. Recent news highlights underperformance compared to defense-focused aerospace ETFs and pressure from Middle East conflicts driving up airline operating expenses.
The outlook remains challenging with fuel cost volatility and competitive pressure from alternative aerospace investments. While travel demand provides some support, the ETF's concentration on airline operators exposes investors to cyclical industry risks and margin compression from elevated fuel expenses. Near-term performance depends on fuel price stabilization and geopolitical developments.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
JETS provides targeted exposure to the global airline industry, including commercial airlines, aircraft manufacturers, and airport operators. It focuses on major U.S. and international carriers like Delta, United, and American Airlines.
Read more on JETS →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →